DCF 57.25(2)(c)1. 1. Self-administration is authorized in writing from the prescribing practitioner.

DCF 57.25(2)(c)2. 2. There is no demonstrated history of risk that the resident may harm self through abuse or overdose.

DCF 57.25(2)(c)3. 3. The resident’s treatment plan includes an evaluation by the program director of the resident’s capability to self-administer medication.

DCF 57.25(2)(c)4. 4. The resident recognizes and distinguishes the medication or treatment and knows the condition or illness for which the medication or treatment is prescribed, the correct dosage, and when the medication or treatment is to be taken.

DCF 57.25(2)(c)5. 5. The medication is not a psychotropic medication as defined in sub. (7) (a).

DCF 57.25(3) (3) Medication Administration documentation.

DCF 57.25(3)(a) (a) Immediately upon administering medication to a resident or a resident self-administering medication, the staff member administering or supervising the administration of medication shall write all of the following in the resident’s record:

DCF 57.25(3)(a)1. 1. Full name of the resident to whom the medication was administered.

DCF 57.25(3)(a)2. 2. Date and time the medication was administered.

DCF 57.25(3)(a)3. 3. Name and dosage of the medication administered or medical treatments received.

DCF 57.25(3)(a)4. 4. Signature of the staff member who administered or supervised the administration of medication.

DCF 57.25(3)(a)5. 5. Any refusal of medication.

DCF 57.25(3)(a)6. 6. Any adverse reaction to the medication and steps taken to notify the resident’s health care provider, parent, guardian, or legal custodian.

DCF 57.25(3)(a)7. 7. Any error in medication administration and the steps taken to notify the resident’s physician as required in sub. (5).

DCF 57.25(3)(b) (b) Each entry made under this subsection shall be written in ink.

DCF 57.25(4) (4) Adverse reaction to medication. In the event of an adverse reaction to any medication, a staff member shall immediately notify the resident’s parent or guardian and the attending physician.

DCF 57.25(5) (5) Medication errors. The attending physician shall be notified in the event of a medication error. The department and placing agency shall be notified as required in ss. DCF 57.13 (1) (e) and 57.135.

DCF 57.25(6) (6) Medication storage and disposal. The licensee shall comply with all of the following requirements for storing medication:

DCF 57.25(6)(a) (a) Medication including over-the-counter medication, shall be kept in the container in which it was purchased or prescribed. No person may transfer medication that has been prescribed or purchased over-the-counter to another container or change the label on any medication, unless the person is a pharmacist as defined in s. 450.01 (15), Stats.

DCF 57.25(6)(b) (b) Medication shall be locked and stored in a location that is inaccessible to children. Only staff members who are designated in writing by the program director shall have access to keys to the medication. Prescription and over-the-counter medication shall not be stored next to chemicals or other contaminants.

DCF 57.25(6)(c) (c) Medication shall be kept under acceptable conditions of sanitation, temperature, light, moisture, and ventilation according to the requirements of each medication. Medication that requires refrigeration shall be stored in a separate locked compartment or container that is properly labeled, stored separately from food items, and kept inaccessible to children.

DCF 57.25(6)(d) (d) Medication for internal consumption shall be stored separately from medication for external application.

DCF 57.25(6)(e) (e) Within 72 hours of the medication’s expiration date, the date the medication is no longer in use by the resident for whom the medication was prescribed or purchased, or the date the resident is discharged, unused medication shall be returned to a parent, guardian, or legal custodian of the resident, for removal from the group home or shall be destroyed by the group home manager or returned to the prescribing pharmacy to be destroyed.

DCF 57.25(6)(f) (f) The group home shall maintain a log of medication destroyed. The information logged shall be written in ink and shall include the amount of medication destroyed, the name of the staff member who destroyed the medication, and the name of the resident to whom the medication belongs. Whenever medication is released to a resident’s parent, guardian or legal custodian, that information, including the name of the person receiving the medication, shall be documented in the resident’s record.

DCF 57.25(6)(g) (g) The group home shall contact the local police to destroy the medications or contact the Division Officer at the U.S. Drug Enforcement Agency (DEA) for instructions for destroying controlled substances.

DCF 57.25 Note Note: The address and phone number for the U.S. Drug Enforcement Agency is 1000 North Water Street, Milwaukee, WI 53202, or call [phone], extension 5300.

DCF 57.25(7) (7) Psychotropic medication.

DCF 57.25(7)(a) (a) Definitions. In this subsection, “psychotropic medication” means any drug that affects the mind and is used to manage inappropriate resident behavior or psychiatric symptoms and may include an anti-psychotic, an antidepressant, lithium carbonate or a tranquilizer.

DCF 57.25(7)(b) (b) Rights of patients. A group home shall comply with the provisions of s. 51.61 (1) (g) and (h), Stats., for each resident who is prescribed psychotropic medication.